Evaluation of the Antitumor Activity of Omipalisib, a PI3K/AKT/MTOR Pathway Inhibitor, on Burkitt Lymphoma Cell Line
Article in Cumhuriyet Science Journal (December 2023)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Article in Cumhuriyet Science Journal (December 2023)
Preprint in Research Square (November 2022)
Article in Cancer Treatment and Research Communications (June 2022)